GE HealthCare Technologies Inc. $GEHC Shares Sold by Optimum Investment Advisors

Optimum Investment Advisors decreased its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 19.0% during the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 1,283 shares of the company’s stock after selling 300 shares during the period. Optimum Investment Advisors’ holdings in GE HealthCare Technologies were worth $95,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. GAMMA Investing LLC increased its position in shares of GE HealthCare Technologies by 19.2% in the first quarter. GAMMA Investing LLC now owns 9,559 shares of the company’s stock worth $772,000 after acquiring an additional 1,543 shares in the last quarter. Spire Wealth Management boosted its position in GE HealthCare Technologies by 5.2% during the 1st quarter. Spire Wealth Management now owns 3,367 shares of the company’s stock worth $272,000 after purchasing an additional 166 shares during the period. Bessemer Group Inc. increased its holdings in GE HealthCare Technologies by 24.3% in the 1st quarter. Bessemer Group Inc. now owns 6,671 shares of the company’s stock valued at $538,000 after purchasing an additional 1,306 shares in the last quarter. Golden State Wealth Management LLC raised its position in GE HealthCare Technologies by 134.2% in the first quarter. Golden State Wealth Management LLC now owns 4,380 shares of the company’s stock valued at $354,000 after purchasing an additional 2,510 shares during the period. Finally, Sequoia Financial Advisors LLC lifted its stake in shares of GE HealthCare Technologies by 5.5% during the first quarter. Sequoia Financial Advisors LLC now owns 15,131 shares of the company’s stock worth $1,221,000 after purchasing an additional 791 shares in the last quarter. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Stock Performance

GE HealthCare Technologies stock opened at $78.14 on Friday. GE HealthCare Technologies Inc. has a 52 week low of $57.65 and a 52 week high of $94.80. The company has a current ratio of 1.16, a quick ratio of 0.93 and a debt-to-equity ratio of 0.85. The stock has a market cap of $35.68 billion, a P/E ratio of 16.01, a price-to-earnings-growth ratio of 2.99 and a beta of 1.13. The stock has a 50 day moving average of $74.78 and a 200-day moving average of $72.53.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.91 by $0.15. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The firm had revenue of $5 billion for the quarter, compared to analysts’ expectations of $4.96 billion. During the same period in the prior year, the company posted $1.00 earnings per share. The firm’s quarterly revenue was up 3.5% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. On average, analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 24th will be given a dividend of $0.035 per share. The ex-dividend date of this dividend is Friday, October 24th. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 2.87%.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on GEHC. BTIG Research increased their target price on GE HealthCare Technologies from $87.00 to $89.00 and gave the company a “buy” rating in a research note on Monday, October 13th. Zacks Research cut GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a report on Monday, September 29th. Morgan Stanley set a $74.00 price objective on shares of GE HealthCare Technologies in a research note on Thursday, September 18th. Barclays started coverage on shares of GE HealthCare Technologies in a research report on Monday, October 13th. They set an “equal weight” rating and a $86.00 target price on the stock. Finally, Wall Street Zen downgraded shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, September 20th. Six research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $85.20.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.